New Metrics for Evaluating Viral Respiratory Pathogenesis.
about
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.A mouse model for MERS coronavirus-induced acute respiratory distress syndrome.Characteristic plethysmographic findings in a guinea pig model of COPD.Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant.Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
P2860
New Metrics for Evaluating Viral Respiratory Pathogenesis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
New Metrics for Evaluating Viral Respiratory Pathogenesis.
@ast
New Metrics for Evaluating Viral Respiratory Pathogenesis.
@en
type
label
New Metrics for Evaluating Viral Respiratory Pathogenesis.
@ast
New Metrics for Evaluating Viral Respiratory Pathogenesis.
@en
prefLabel
New Metrics for Evaluating Viral Respiratory Pathogenesis.
@ast
New Metrics for Evaluating Viral Respiratory Pathogenesis.
@en
P2860
P1433
P1476
New Metrics for Evaluating Viral Respiratory Pathogenesis.
@en
P2093
Lisa E Gralinski
Martin T Ferris
P2860
P304
P356
10.1371/JOURNAL.PONE.0131451
P407
P577
2015-06-26T00:00:00Z